A phase II, randomized study of aprepitant in the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients

The present study aimed to study the efficacy of aprepitant in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC) for colorectal cancer (CRC), and comprised a multicenter, phase II, open-label, randomized, parallel compara...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Clin Oncol
Auteurs principaux: ARIDOME, KUNIAKI, MORI, SHIN-ICHIROU, BABA, KENJI, YANAGI, MASAYUKI, HAMANOUE, MASAHIRO, MIYAZONO, FUTOSHI, TOKUDA, KOUKI, IMAMURA, HIROSHI, OGURA, YOSHITO, KANEKO, KOUICHI, KIJIMA, FUMIO, MAEMURA, KOUSEI, ISHIGAMI, SUMIYA, NATSUGOE, SHOJI
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2016
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774568/
https://ncbi.nlm.nih.gov/pubmed/26998290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.724
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires